EMEA-001301-PIP02-12-M03
Key facts
| Invented name |
Cresemba
|
| Active substance |
Isavuconazonium sulfate
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0100/2019
|
| PIP number |
EMEA-001301-PIP02-12-M03
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
|
| Contact for public enquiries |
Basilea Pharmaceutica International Ltd.
Tel. +41 616061400 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|